Dannex Ayrton Starwin (XGHA:DASPHARMA) Interest Coverage: 0 (At Loss) (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XGHA:DASPHARMA Dannex Ayrton Starwin PLC XGHA:DASPHARMA
4 GF Score
Price GHS0.44
! 1 Warning Sign
View Full Analysis

What is Dannex Ayrton Starwin Interest Coverage?

Dannex Ayrton Starwin XGHA:DASPHARMA 4 Interest Coverage is 0 (At Loss) as of . 20. GuruFocus rates XGHA:DASPHARMA with a GF Score™ of 4/100. The stock has 1 warning sign investors should review. Among 688 Drug Manufacturers companies, Dannex Ayrton Starwin ranks worse than 145348.69% on this metric.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Dannex Ayrton Starwin's Operating Income for the six months ended in . 20 was GHS0.00 Mil. Dannex Ayrton Starwin's Interest Expense for the six months ended in . 20 was GHS0.00 Mil. did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is.

(1) Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for Dannex Ayrton Starwin's Interest Coverage or its related term are showing as below:


XGHA:DASPHARMA's Interest Coverage is not ranked *
in the Drug Manufacturers industry.
Industry Median: 12.765
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Dannex Ayrton Starwin  (XGHA:DASPHARMA) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Dannex Ayrton Starwin Interest Coverage Related Terms


Dannex Ayrton Starwin Interest Coverage Historical Data

* Premium members only.

The historical data trend for Dannex Ayrton Starwin's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Dannex Ayrton Starwin Interest Coverage Chart

Dannex Ayrton Starwin Annual Data
Trend
Interest Coverage

Dannex Ayrton Starwin Semi-Annual Data
Interest Coverage

XGHA:DASPHARMA vs : Interest Coverage Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Dannex Ayrton Starwin's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dannex Ayrton Starwin Interest Coverage vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dannex Ayrton Starwin's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Dannex Ayrton Starwin's Interest Coverage falls into.


XGHA:DASPHARMA
4GF Score
Dannex Ayrton Starwin PLC XGHA:DASPHARMA
Interest Coverage is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dannex Ayrton Starwin Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Dannex Ayrton Starwin's Interest Coverage for the fiscal year that ended in . 20 is calculated as

Here, for the fiscal year that ended in . 20, Dannex Ayrton Starwin's Interest Expense was GHS0.00 Mil. Its Operating Income was GHS0.00 Mil. And its Long-Term Debt & Capital Lease Obligation was GHS0.00 Mil.

Dannex Ayrton Starwin had no debt (1).

Dannex Ayrton Starwin's Interest Coverage for the quarter that ended in . 20 is calculated as

Here, for the six months ended in . 20, Dannex Ayrton Starwin's Interest Expense was GHS0.00 Mil. Its Operating Income was GHS0.00 Mil. And its Long-Term Debt & Capital Lease Obligation was GHS0.00 Mil.

Dannex Ayrton Starwin had no debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.

Frequently Asked Questions Learn more about Interest Coverage →
What does a Interest Coverage of 0 (At Loss) mean?
Dannex Ayrton Starwin (XGHA:DASPHARMA) has a Interest Coverage of 0 (At Loss) as of . 20. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Dannex Ayrton Starwin and its competitors. According to the industry distribution chart, Dannex Ayrton Starwin ranks #999999 out of 688 companies in the Drug Manufacturers industry.
Is Dannex Ayrton Starwin's Interest Coverage too high?
Dannex Ayrton Starwin's current Interest Coverage is 0 (At Loss). Based on the distribution chart, Dannex Ayrton Starwin ranks #999999 out of 688 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Dannex Ayrton Starwin has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Dannex Ayrton Starwin's Interest Coverage compare to ?
According to the Drug Manufacturers industry distribution chart, Dannex Ayrton Starwin ranks #999999 out of 688 companies for Interest Coverage. This places Dannex Ayrton Starwin in the lower half of its industry. The industry median Interest Coverage is 12.77. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.77, based on 688 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Dannex Ayrton Starwin and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dannex Ayrton Starwin's current Interest Coverage is 0 (At Loss). However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dannex Ayrton Starwin stock overvalued right now?
Dannex Ayrton Starwin (XGHA:DASPHARMA) has a current Interest Coverage of 0 (At Loss). The current Interest Coverage is 0 (At Loss). Dannex Ayrton Starwin's overall GF Score™ is 4/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Dannex Ayrton Starwin (XGHA:DASPHARMA), the current Interest Coverage is 0 (At Loss) as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Dannex Ayrton Starwin Business Description

Comparable Companies
Address No. 5 Dadeban Road, Ring Road North, North Industrial Area, Accra, GHA
Dannex Ayrton Starwin PLC is a pharmaceutical company. The company offers a product range that includes tablets, capsules, liquids syrups and suspensions, powders, ointments, and chemicals. It also manufactures and distributes Vitamin C.
4GF Score

Get the complete analysis for XGHA:DASPHARMA

Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

GHS0.44
Price